Merus N.V. Common Shares (MRUS)

Merus N.V. (MRUS) stock surges to a 52-week high following Genmab acquisition news and positive clinical trial results. Increased social media buzz reflects strong market confidence.

About Merus N.V. Common Shares

Merus N.V. is a biotechnology company focused on developing antibody-based therapeutics for cancer.
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

• Merus N.V. Common Shares (MRUS) social dominance is up 156.67% from the previous week.
• Merus N.V. Common Shares (MRUS) Galaxy Score™ is up 34.62% from the previous week.
• Merus N.V. Common Shares (MRUS) sentiment is up 34% from the previous week.
• Merus N.V. Common Shares (MRUS) engagements is up 133.45% from the previous week.

Price: $90

Price 24-Hour Time-Series Raw Data
The stock price has surged to a 52-week high, driven by acquisition news from Genmab at a significant premium and positive clinical trial results, with increased social media activity reflecting strong market confidence.

24-Hour: -7.08%

1-Year High: $97 on 2025-12-19
1-Year Low: $34.90 on 2025-04-08

AltRank: [-----]

AltRank 24-Hour Time-Series Raw Data
Merus N.V. Common Shares (MRUS) is currently AltRank #1,631 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [------]
[--] Month: [---] +89
[--] Months: [---] +331
[--] Year: [---] [----]
1-Year High: [-----] on 2026-01-28
1-Year Low: [--] on 2025-05-24

Galaxy Score: [-----]

Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +9
[--] Month: [--] +7
[--] Months: [--] [---]
[--] Year: [--] +4
1-Year High: [--] on 2025-07-10
1-Year Low: [--] on 2025-12-11

Engagements: [---] (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [-----] +133%
[--] Month: [------] -92%
[--] Months: [---------] -8%
[--] Year: [---------] -33%
1-Year High: [-------] on 2025-09-29
1-Year Low: [--] on 2026-02-08

Engagements by network (24h): Reddit: [--] X: [---]

Mentions: [--] (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -11%
[--] Month: [---] -23%
[--] Months: [-----] -49%
[--] Year: [-----] +285%
1-Year High: [-----] on 2025-07-10
1-Year Low: [--] on 2025-12-07

Mentions by network (24h): Reddit: [--] X: [--]

Creators: [--] (24h)

Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last [--] hours which is up 27% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -3.20%
[--] Month: [--] -34%
[--] Months: [-----] -53%
[--] Year: [-----] +497%
1-Year High: [---] on 2025-09-29
1-Year Low: [--] on 2025-12-07

Sentiment: 100%

Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 77%
[--] Week: 67% +17%
[--] Month: 83% -3%
[--] Months: 83% -11%
[--] Year: 83% +33%
1-Year High: 100% on 2025-04-13
1-Year Low: 27% on 2025-03-02

Most Supportive Themes:

• Positive Clinical Trial Results: (40%) Merus N.V. Common Shares (MRUS) has shown positive clinical trial results, contributing to market confidence.
• Acquisition News: (35%) The company is experiencing increased social media activity due to acquisition news from Genmab at a significant premium.

Most Critical Themes:

Social Dominance: 0.00156%

Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00156%
Daily Average: 0.013%
[--] Week: 0.00154% +0.00094%
[--] Month: 0.0014% -0.0035%
[--] Months: 0.0014% -0.013%
[--] Year: 0.0014% -0.0045%
1-Year High: 0.153% on 2025-07-10
1-Year Low: 0.0008% on 2025-12-07

Market Dominance: 0.00764%

Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00764%
Daily Average: 0%
1-Year High: 0.013% on 2025-03-31
1-Year Low: 0.00373% on 2025-02-17

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing